A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Completed · Phase 4 · Has a placebo group

Conditions studied: Post-Menopausal Osteopenia

In brief

This 2 arm study will evaluate the efficacy and safety of oral Bonviva 150mg once monthly compared with placebo in post-menopausal women with osteopenia. Patients will be randomized to receive either Bonviva 150mg po monthly, or placebo monthly. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.

Key facts

Study ID
NCT00129623
Run by
Hoffmann-La Roche
People needed
160
Starts
2005-12-01
Expected to finish
2007-12-01
Last updated by the study team
2016-01-11

Who can join

Age: 45 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.